De-Novo Belatacept Therapy is Associated with an Increased Risk of Invasive CMV Disease After Kidney Transplantation.

被引：0
|
作者：
Petrossian, G. [1 ]
Ortiz, J. [2 ]
Addonizio, K. [1 ]
Hsiao, A. [1 ]
Teixeira, L. [1 ]
Koizumi, N. [3 ]
James, R. [3 ]
Patel, S. [4 ]
Conti, D. [2 ]
Plews, R. [2 ]
机构：
[1] Albany Med Ctr, Albany, NY USA
[2] Albany Med Ctr, Div Renal & Pancreat Transplant Serv, Albany, NY USA
[3] George Mason Univ, Fairfax, VA 22030 USA
[4] UMC Las Vegas, Las Vegas, NV USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
413
引用
收藏
页码：512 / 512
页数：1
相关论文
共 50 条
  • [41] Induction therapy is not associated with increasing risk of cancer after renal transplantation.
    Harzallah, Kois
    Frimat, Lionel
    Kessler, Michele
    Giral, Magali
    Foucher, Yvon
    Soullilou, Jean Paul
    Dantal, Jacques
    CLINICAL IMMUNOLOGY, 2006, 119 : S98 - S98
  • [42] Long Term Follow Up of De Novo Use of mTOR Inhibitors (mTORi) After Kidney Transplantation.
    Paula, M.
    Hannun, P.
    Felipe, C.
    Ferreira, A.
    Cristelli, M.
    Franco, M.
    Tedesco, H.
    Medina-Pestana, J.
    TRANSPLANTATION, 2014, 98 : 543 - 544
  • [43] Targeted preemptive therapy according to perceived risk of CMV infection after kidney transplantation
    Pinto, Cahue Henrique
    Tedesco-Silva, Helio, Jr.
    Felipe, Claudia Rosso
    Ferreira, Alexandra Nicolau
    Cristelli, Marina
    Viana, Laila Almeida
    Aguiar, Wilson
    Medina-Pestana, Jose
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2016, 20 (06): : 576 - 584
  • [44] DE NOVO ANCA-ASSOCIATED VASCULITIS 20 MONTHS AFTER KIDNEY TRANSPLANTATION
    Sagmeister, M.
    Eichhom, P.
    Habicht, A.
    Stangl, M.
    Fischereder, M.
    Schoenermarck, U.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 26 - 26
  • [45] Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury
    Bucaloiu, Ion D.
    Kirchner, H. Lester
    Norfolk, Evan R.
    Hartle, James E., II
    Perkins, Robert M.
    KIDNEY INTERNATIONAL, 2012, 81 (05) : 477 - 485
  • [46] DE NOVO HEART FAILURE AFTER KIDNEY TRANSPLANTATION: EPIDEMIOLOGY, RISK FACTORS AND OUTCOMES
    Van Rhijn, Peter
    Mark, Patrick
    Thomson, Peter
    Mangion, Kenneth
    Stoumpos, Sokratis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I711 - I711
  • [47] HYPERURICEMIA IS ASSOCIATED WITH DE NOVO CHRONIC KIDNEY DISEASE AFTER PARTIAL NEPHRECTOMY
    Woo, Jason
    Lee, Hak
    Wang, Song
    Liss, Michael
    Patel, Nishant
    Jabaji, Ramzi
    Elkhoury, Fuad
    McDonald, Michelle
    Palazzi, Kerrin
    Mehrazin, Reza
    Patterson, Anthony
    Derweesh, Ithaar
    JOURNAL OF UROLOGY, 2014, 191 (04): : E390 - E390
  • [48] DE NOVO INFLAMMATORY BOWEL DISEASE AFTER KIDNEY TRANSPLANTATION - REPORT OF THREE CASES
    Obrencevic, Katarina
    Petrovia, Marijana
    Vavic, Neven
    Petrovic, Stanko
    Tufegdzic, Ivana
    Rabrenovic, Violeta
    Tadia, Jelena
    Mijuskovic, Mirjana
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2105 - 2105
  • [49] Negative Impact of De Novo Donor-Specific Anti-HLA Antibodies (De Novo DSA) after Living Donor Kidney Transplantation.
    Omoto, Kazuya
    Ishida, Hideki
    Shimizu, Tomokazu
    Shirakawa, Hiroki
    Toki, Daisuke
    Iida, Shouichi
    Tokita, Daisuke
    Furusawa, Miyuki
    Tanabe, Kazunari
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 585 - 585
  • [50] De novo minimal change disease after ABO-incompatible kidney transplantation
    Mochizuki, Yasushi
    Iwata, Takahisa
    Nishikido, Masaharu
    Uramatsu, Tadashi
    Sakai, Hideki
    Taguchi, Takashi
    CLINICAL TRANSPLANTATION, 2012, 26 : 81 - 85
12345